title: Bone mineral density screening should be routine in lymphoma patients.
authors.affiliation: Aurora Research Institute, Aurora Health Care, Milwaukee. Electronic address: michael.a.thompson@aurora.org.
authors.forename: M A
authors.initials: MA
authors.lastname: Thompson
authors.affiliation: Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
authors.forename: J R
authors.initials: JR
authors.lastname: Westin
authors.affiliation: Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
authors.forename: F B
authors.initials: FB
authors.lastname: Hagemeister
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001862:Bone Resorption / Q000097:blood*; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male
chemical_list: D000970:Antineoplastic Agents